Biotech Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. July 20, 2026
Biotech 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population July 18, 2026
Biotech REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting July 18, 2026
Biotech DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales July 17, 2026
Biotech CPC Biotech Introduces One-Inch Flow Path, Single-Use Sterile Disconnect for Bioprocessing July 15, 2026